From Bench To Bedside, Another Practice-changing Treatment Is On The Road!

12 Mar, 2021

Dr. Rajesh Bollam

Image

From bench to bedside, another practice-changing treatment is on the road!

🔶The oral HIF-2 α inhibitor Belzutifan in patients with advanced ccRCC previously treated with a median of the previous 3 lines!

🔶ORR 25%

🔶SD 55%,

🔶DCR (CR+PR+SD) 80%.

🔶mDOR NR

#DrRajeshBollam #kidneycancer #clinicaltrials #CancerSpecialist #HematoOncologist #cancerdoctor #RCC #Hyderabad

Add a comment